Tales of medical device translation in biomedical engineering including the role of telehealth in the COVID-19 era
As a response to the increasing burden of chronic disease and the ageing population on health care expenditure, considerable focus has been placed on appropriate technologies for promoting self-care and for supporting ageing-in-place. Such technologies are even more critical in the face of emerging health threats such as the COVID-19 pandemic,
A number of medical device technologies aimed at relieving the burden of disease and improving quality of life will be explored. These devices, developed at the Graduate School of Biomedical Engineering, UNSW over the past two decades include telehealth monitoring and decision support systems for chronic disease management; wearable ambulatory technologies based around triaxial accelerometry for estimating risks of falling and for automatically detecting falls; and a range of neural interface technologies for restoring and potentially augmenting sensory loss. Learning objectives would include:
A number of medical device technologies aimed at relieving the burden of disease and improving quality of life will be explored. These devices, developed at the Graduate School of Biomedical Engineering, UNSW over the past two decades include telehealth monitoring and decision support systems for chronic disease management; wearable ambulatory technologies based around triaxial accelerometry for estimating risks of falling and for automatically detecting falls; and a range of neural interface technologies for restoring and potentially augmenting sensory loss. Learning objectives would include:
- Gaining a broad understanding of the processes involved in medical device translation from concept, to trials, regulatory approvals and commercialisation
- Understanding of the types of telehealth technologies and data analytic tools that can be used for managing the burden of chronic disease
- Exposure to a range of novel neural interface technologies for improving the efficacy of neural implants
- A discussion on the future of implantable, wearable and telehealth technologies in future models of patient care and health service delivery especially in the current global crisis
Nigel Lovell received the B.E. (Hons) and Ph.D. degrees from UNSW Sydney, Australia. He is currently at the Graduate School of Biomedical Engineering UNSW Sydney where he holds a position of Scientia Professor and Head of School. He has authored 290+ journal papers and been awarded over USD$60 million in R&D and infrastructure funding. Over his career he has mentored 70 PhD students and delivered more than a hundred keynote presentations. He is a Fellow of seven learned academies throughout the world including ATSE, the IEEE and AIMBE.
His research work has covered areas of expertise ranging from cardiac and retinal modeling, medical informatics and data analytics especially related to telehealth technologies, biological signal processing, and visual prosthesis design. Through a spin-out company from UNSW, TeleMedCare Pty. Ltd., that he co-founded he has commercialised a range of telehealth technologies for managing chronic disease and falls in the older population. He is also one of the key researchers leading an R&D program to develop in Australia a retinal neuroprosthesis or ‘bionic eye’. For 2017 and 2018 he was the President of the world’s largest biomedical engineering society – the IEEE Engineering in Medicine and Biology Society.
Prof Nigel Lovell
Graduate School of Biomedical Engineering
University of New South Wales
UNSW Sydney NSW 2052 Australia
Ph: +61-2-93853922
Email: [email protected]
Web: https://research.unsw.edu.au/people/scientia-professor-nigel-lovell
His research work has covered areas of expertise ranging from cardiac and retinal modeling, medical informatics and data analytics especially related to telehealth technologies, biological signal processing, and visual prosthesis design. Through a spin-out company from UNSW, TeleMedCare Pty. Ltd., that he co-founded he has commercialised a range of telehealth technologies for managing chronic disease and falls in the older population. He is also one of the key researchers leading an R&D program to develop in Australia a retinal neuroprosthesis or ‘bionic eye’. For 2017 and 2018 he was the President of the world’s largest biomedical engineering society – the IEEE Engineering in Medicine and Biology Society.
Prof Nigel Lovell
Graduate School of Biomedical Engineering
University of New South Wales
UNSW Sydney NSW 2052 Australia
Ph: +61-2-93853922
Email: [email protected]
Web: https://research.unsw.edu.au/people/scientia-professor-nigel-lovell